110Chapter 9:Stronger commissioningChapter Summary●●●●●Strong cancer commissioning will be vital to delivering world class cancer services;The recommendations in World Class Commissioning are directly applicable to cancerservices;In future cancer networks will play a central role, reporting to PCTs in commissioning cancerservices;This chapter includes a series of measures to strengthen the support available tocommissioners, including publishing a cancer commissioning guide and planning toolkit; andCommissioners should also use existing national guidance and standards and the process ofpeer review to assist them in making commissioning decisions for cancer.Introduction9.1 This strategy reflects a progressive transitionaway from central command towards greaterlocal control in health services. The <strong>NHS</strong> will beempowered and incentivised to drive up thequality of cancer care at a local level and to beresponsive to the needs of the local population.9.2 Everyone with a commitment to deliveringworld class cancer services should have a role toplay in helping deliver this strategy. However,strong commissioning will be particularlyimportant. This chapter sets out the newsupport which will be available tocommissioners, as well as some of the leversand tools which good commissioners will usewhen planning service improvements.Enabling strong commissioningfor cancer9.3 Strong cancer commissioning is vital toensuring that high quality services are deliveredwhich reflect national priorities, the needs oflocal populations and offer good value formoney. Responsibility for the implementationof most of this strategy will rest with PrimaryCare Trust (PCT) Boards as the statutory bodiesresponsible for commissioning the full range ofservices for their population within theirallocated budgets.9.4 To achieve the goals of this strategy, PCTswill need to work in closer partnership withother PCTs and their supporting practice basedcommissioning and specialised commissioningarrangements, taking strategic decisions to shapehow and where care is best delivered. They willneed to secure comprehensive services for cancerfor their population, that are coordinated acrossthe care pathway, including health promotion,social services, preventative and other servicesprovided jointly with local authorities.9.5 In the past, commissioning for cancerservices has not been as effective as it mighthave been. Peer Review has shown that whilst25% of networks have demonstrated thateffective collective commissioning arrangementsare in place, with an agreed three year strategic
CHAPTER 9: STRONGER COMMISSIONING 111framework for planning future cancer servicesand clearly identified priorities, a further 25%were found to be struggling in all these areas.This, therefore, remains an important area fordevelopment.9.6 It is important to recognise thatcommissioning for cancer is particularly complex.There are many different types of cancer, eachwith a different care pathway involving clinicalteams in the community, in acute generalhospitals and in specialist centres. Some aspectsof the diagnosis and treatment of cancer arerare and require highly specialisedcommissioning at a national or Strategic HealthAuthority (SHA) level. Other aspects of cancerare common and overlap with non-cancerservices (such as endoscopy, imaging, pathologyand some surgery) and thus should becommissioned at a more local level.●●As mentioned in chapter 8, an electroniccommissioning toolkit, is beingdeveloped to provide SHAs, SpecialistCommissioning Groups (SCGs), cancernetworks, PCTs and <strong>NHS</strong> Trusts withcomparative data on incidence, survivaland mortality from cancer and oninformation available from nationalsources such as hospital episodestatistics. The <strong>Cancer</strong> Action Team willsupport networks in using this toolkitand will commission upgrades as andwhen is necessary; andService specifications for each cancerpathway are being developed, whichwill be linked to the Map of Medicine,a process which offers high qualityclinical information, linked to the <strong>NHS</strong>IT Programme.9.7 A significant amount of cancer care is bestcommissioned at populations of one to twomillion people because of the critical massrequired to provide effective care. This includesradiotherapy, specialist surgical services forupper gastrointestinal, urological, gynaecologicaland head and neck cancers and aspects ofchemotherapy. For this reason we continue torecommend that cancer commissioning iscoordinated across a network of care, based onpatient care pathways into these services, ratherthan formal organisational boundaries.9.8 The Department of Health has publishedWorld Class Commissioning, which sets out howPCTs should ensure strong commissioning acrossall health services. A support and developmentframework will be available in 2008 to help PCTsgain the capability to become world class. The<strong>Cancer</strong> <strong>Reform</strong> <strong>Strategy</strong> sets out specific supportthat will be available to cancer commissioners.9.9 To strengthen commissioning of cancerservices the following actions are alreadybeing taken:●A guide for cancer commissioners,is currently in development, this willset out the appropriate level for thecommissioning of different cancer services;9.10 Given the cross-organisational way inwhich many cancer services are delivered,collaboration should be an important part ofcancer commissioning:●●●●Patients, local voluntary service providers,alternative providers and other stakeholdersshould be involved in influencing the way inwhich services develop;Commissioners and providers should worktogether to improve service quality andsafety and plan future provision;Clinicians and managers should collectivelydrive forward innovation in the way servicesare delivered; andPCTs should work together to developstrategies and agree priorities.9.11 <strong>Cancer</strong> networks play an essential role infostering this collaboration. PCTs in somenetworks have been very successful at bringingtogether the relevant commissioningpartnerships to plan and monitor servicedelivery. Other networks have lacked PCTengagement and network teams have largelyworked with providers in isolation ofmainstream health economy systems.